MacroGenics completes $122.5M sale of GMP manufacturing to Bora Pharmaceuticals

MACROGENICS INC

Closed sale of GMP manufacturing (CDMO) to Bora Pharmaceuticals for $122.5M cash, subject to post-closing adjustments.
Bora assumes Rockville, MD facility and Frederick, MD warehouse; ~140 former MacroGenics employees hired by Bora.
MacroGenics enters supply agreement with Bora for process development and drug substance production for pipeline.
Pro forma cash and equivalents rise to $177.2M from $66.5M; estimated gain on sale of $106.1M recorded.
Up to $5M in contingent consideration possible upon manufacturing milestones in 2027-2028.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.